XML 151 R133.htm IDEA: XBRL DOCUMENT v3.24.0.1
Schedule II. Condensed Financial Information Of Registrant - Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net Cash Provided by (Used in) Operating Activities [Abstract]      
Net income (loss) attributable to RenaissanceRe $ 2,561,132 $ (1,061,203) $ (40,155)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities      
Net realized and unrealized (gains) losses on investments (482,794) 1,635,192 205,897
Other (579,280) (259,168) (437,221)
Net cash provided by (used in) operating activities 1,911,634 1,603,683 1,234,815
Net Cash Provided by (Used in) Investing Activities [Abstract]      
Proceeds from maturities and sales of fixed maturity investments trading 21,796,577 22,086,168 15,543,565
Purchases of fixed maturity investments trading (24,771,411) (24,923,131) (15,680,351)
Net sales (purchases) of short term investments 1,843,180 640,411 (252,833)
Return of investment from investment in other ventures 5,554 2,248 8,345
Net purchase of Validus (2,433,746) 0 0
Net cash provided by (used in) investing activities (3,822,636) (3,016,176) (816,296)
Cash flows provided by (used in) financing activities      
Dividends paid – RenaissanceRe common shares (75,112) (64,675) (67,828)
Dividends paid – preference shares (35,375) (35,396) (32,889)
Issuance of debt, net of expenses 740,581 0 0
RenaissanceRe common share repurchases 0 (166,664) (1,027,505)
RenaissanceRe common share issuance 1,351,608 0 0
Redemption of preference shares 0 0 (275,000)
Issuance of preference shares, net of expenses 0 0 488,653
Taxes paid on withholding shares (20,518) (10,911) (12,171)
Net cash provided by (used in) financing activities 2,588,639 725,342 (302,461)
Effect of exchange rate changes on foreign currency cash 5,542 22,471 6,148
Net increase (decrease) in cash and cash equivalents 683,179 (664,680) 122,206
Cash and cash equivalents, beginning of year 1,194,339 1,859,019 1,736,813
Cash and cash equivalents, end of year 1,877,518 1,194,339 1,859,019
Parent Company      
Net Cash Provided by (Used in) Operating Activities [Abstract]      
Net income (loss) attributable to RenaissanceRe 2,561,131 (1,061,204) (40,155)
Less: equity in net income of subsidiaries (2,708,061) 988,610 10,670
Loss before equity in net income of subsidiaries (146,930) (72,594) (29,485)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities      
Net realized and unrealized (gains) losses on investments 67,868 2,051 4,898
Other 72,691 36,601 59,873
Net cash provided by (used in) operating activities (6,371) (33,942) 35,286
Net Cash Provided by (Used in) Investing Activities [Abstract]      
Proceeds from maturities and sales of fixed maturity investments trading 1,613,740 198,341 436,122
Purchases of fixed maturity investments trading (1,505,160) (375,804) (421,323)
Net sales (purchases) of short term investments (211,370) (21,037) 78,904
Return of investment from investment in other ventures 1,097,301 1,009,108 1,104,831
Contributions to subsidiaries (169,204) (349,336) (351,548)
Due to (from) subsidiary (7,088) (178,470) 50,472
Net cash provided by (used in) investing activities (1,916,781) 282,802 897,458
Cash flows provided by (used in) financing activities      
Dividends paid – RenaissanceRe common shares (75,112) (64,675) (67,828)
Dividends paid – preference shares (35,375) (35,396) (32,889)
Issuance of debt, net of expenses 740,581 0 0
RenaissanceRe common share repurchases 0 (166,664) (1,027,505)
RenaissanceRe common share issuance 1,351,608 0 0
Redemption of preference shares 0 0 (275,000)
Issuance of preference shares, net of expenses 0 0 488,653
Taxes paid on withholding shares (20,518) (10,911) (12,171)
Net cash provided by (used in) financing activities 1,961,184 (277,646) (926,740)
Effect of exchange rate changes on foreign currency cash 0 0 0
Net increase (decrease) in cash and cash equivalents 38,032 (28,786) 6,004
Cash and cash equivalents, beginning of year 7,048 35,834 29,830
Cash and cash equivalents, end of year 45,080 7,048 35,834
Parent Company | Validus Specialty      
Net Cash Provided by (Used in) Investing Activities [Abstract]      
Due to (from) subsidiary (45,467) 0 0
Parent Company | Validus Holdings, Ltd and Talbot Underwriting Limited      
Net Cash Provided by (Used in) Investing Activities [Abstract]      
Net purchase of Validus $ (2,689,533) $ 0 $ 0